Mouth sores during treatment
Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant
Where to go
1 hospital in India taking patients for this trial.
Registry summary (technical)
The goal of this phase II, single-arm interventional clinical trial is to evaluate whether oral sodium copper chlorophyllin (CHL) can reduce the frequency and severity of oral mucositis in patients aged 12-65 years undergoing myeloablative total body irradiation (TBI) as part of conditioning before their first allogeneic Hematopoietic Stem Cell Transplantation (HSCT). The main questions it aims to answer are: Does oral chlorophyllin reduce the incidence of Grade III and IV oral mucositis by day +28 after HSCT? Does oral chlorophyllin reduce the duration of severe oral mucositis and the need …
Sponsor: Tata Memorial Centre
NCT07709195 on ClinicalTrials.gov
Last updated on the registry 27 Jul 2026 · read by us 20 Oct 2026